Product Program year 2022 Source: CMS Open Payments

PreciseTumor

Device Tumor Dna Genetic Oncology Analysis

Open in the dashboard

General payments

$97,253

614 payments

Research payments

$0

0 payments

Through program year 2022, $97,253 in general payments and $0 in research payments were reported against PreciseTumor (Tumor Dna Genetic Oncology Analysis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $97,253 614

Breakdown

Who paid General payments · program year 2022
  1. Myriad Genetic Laboratories, Inc. $97,253 614 payments
Top recipients General payments · program year 2022
  1. Bradley Monk Gynecologic Oncology · West Palm Beach, FL $14,566 15% · 13 payments
  2. Devesh Pandya Hematology & Oncology · Houston, TX $12,567 13% · 17 payments
  3. Shail Dalal Hematology & Oncology · Palestine, TX $9,233 9% · 12 payments
  4. Dario Roque Gynecologic Oncology · Chicago, IL $4,375 4% · 4 payments
  5. Melissa Hodeib Gynecologic Oncology · Los Angeles, CA $4,200 4% · 3 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Gynecologic Oncology Obstetrics & Gynecology $41,271 42% · 71 practitioners
  2. Hematology & Oncology Internal Medicine $31,456 32% · 118 practitioners
  3. Medical Oncology Internal Medicine $3,875 4% · 42 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $3,061 3% · 48 practitioners
  5. Physician Assistant $3,034 3% · 42 practitioners

The top 5 of 33 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Texas $41,129 42% · 104 recipients
  2. Arizona $14,566 15% · 1 recipient
  3. California $10,567 11% · 45 recipients
  4. New Jersey $4,556 5% · 16 recipients
  5. Illinois $4,503 5% · 7 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

614 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record